Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Bellerophon Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −5 vs. Q2 2021
- Shares held
- 1.18M
- −125.6K (−9.6%) vs. Q2 2021
- Total value
- $4.81M
- −$1.53M (−24.1%) vs. Q2 2021
- New holders
- 1
- 6 more added
- Sold out
- 6
- 10 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $6.37K |
| Q3 2023 | 22 | $506.6K |
| Q2 2023 | 23 | $824.9K |
| Q1 2023 | 19 | $27.9M |
| Q4 2022 | 25 | $832.7K |
| Q3 2022 | 19 | $1.18M |
| Q2 2022 | 19 | $1.40M |
| Q1 2022 | 22 | $2.68M |
| Q4 2021 | 22 | $3.82M |
| Q3 2021 | 22 | $4.81M |
| Q2 2021 | 27 | $6.34M |
| Q1 2021 | 39 | $10.9M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Bellerophon Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 100 | $0 | 0.00% | −6,407−98.5% | Reduced |
| Bank of America Corp | 74 | $0 | 0.00% | −666−90.0% | Reduced |
| Royal Bank of Canada | 174 | $1.00K | 0.00% | −709−80.3% | Reduced |
| Harbour Investments, Inc. | 241 | $1.00K | 0.00% | +99+69.7% | Added |
| Professional Financial Advisors, LLC | 500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 500 | $2.00K | 0.00% | +500 | New |
| UBS Group AG | 1,171 | $4.00K | 0.00% | −2,190−65.2% | Reduced |
| Advisor Group Holdings, Inc. | 1,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1,221 | $5.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,823 | $7.00K | 0.00% | −215−10.5% | Reduced |
| Rockefeller Capital Management L.P. | 5,500 | $22.0K | 0.00% | +1,000+22.2% | Added |
| HRT Financial LP | 11,879 | $48.0K | 0.00% | −1,931−14.0% | Reduced |
| Tudor Investment Corp Et Al | 20,000 | $81.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,327 | $87.0K | 0.00% | +300+1.4% | Added |
| ACT Capital Management, LLC | 25,000 | $102.0K | 0.05% | 00.0% | Unchanged |
| Northern Trust Corp | 36,653 | $149.0K | 0.00% | +98+0.3% | Added |
| Geode Capital Management, LLC | 58,375 | $237.0K | 0.00% | −50.0% | Reduced |
| Telemetry Investments, L.L.C. | 85,500 | $347.0K | 0.47% | −5,420−6.0% | Reduced |
| BlackRock Inc. | 120,620 | $490.0K | 0.00% | +4,138+3.6% | Added |
| Renaissance Technologies LLC | 201,706 | $819.0K | 0.00% | −55,366−21.5% | Reduced |
| Wells Fargo & Company | 250,052 | $1.01M | 0.00% | −204−0.1% | Reduced |
| Vanguard Group Inc | 341,455 | $1.39M | 0.00% | +4,489+1.3% | Added |
| First Trust Advisors LP | 0 | $0 | 0.00% | −20,515−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −16,495−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −13,800−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −12,243−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −50−100.0% | Sold out |